Literature DB >> 10623861

Differential roles of IL-18 in allergic airway disease: induction of eotaxin by resident cell populations exacerbates eosinophil accumulation.

E Campbell1, S L Kunkel, R M Strieter, N W Lukacs.   

Abstract

Cytokine regulation during an allergic response can dictate the severity of the inflammation and resulting injury. In the present study, we have examined the systemic and local effects of IL-18, a Th1-associated cytokine, on a cockroach allergen-induced airway response. In initial studies, temporal increases in IL-18 levels were observed within the lungs. When IL-18 was neutralized systemically the allergen-associated eosinophil accumulation was significantly accelerated 5-fold by 8 h postchallenge, suggesting a regulatory role for IL-18. Recombinant IL-18 (200 ng) was instilled into the airway at the time of allergen challenge to examine whether a direct impact on local eosinophil accumulation could be induced. When IL-18 was instilled, a significant increase in peribronchial eosinophil accumulation was observed in allergic mice as well as in nonallergic mice. A possible mechanism was observed in a significant increase in eotaxin, but not other eosinophil chemotactic factors, in bronchoalveolar lavage fluid after IL-18 instillation. The role of eotaxin was confirmed using eotaxin -/- mice, which demonstrated significantly less eosinophil accumulation compared with littermate controls. IL-18 was subsequently shown to induce eotaxin production from bronchial epithelial cells and isolated macrophages in in vitro assays. The clinical relevance of these findings was determined in treated mice and demonstrated that neutralization of IL-18 exacerbated, whereas exogenous IL-18 had no effect on airway hyperreactivity. Altogether, these data demonstrate that IL-18 may have multiple functions during an immune response that differ depending upon the local or systemic effects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623861     DOI: 10.4049/jimmunol.164.2.1096

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Multiple interleukin-18 injections promote both mouse Th1 and Th2 responses after sublethal Escherichia coli infection.

Authors:  M Kinoshita; N Kuranaga; A Matsumoto; S Ono; N Shinomiya; H Hiraide; S Seki
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

2.  Involvement of interleukin-18 in the pathogenesis of human eosinophilic esophagitis.

Authors:  Rituraj Niranjan; Priya Rajavelu; Sathisha Upparahalli Ventateshaiah; Jai Shankar Shukla; Asifa Zaidi; Siddesha Jalahalli Mariswamy; Jochen Mattner; Ilana Fortgang; Monika Kowalczyk; Luis Balart; Anshi Shukla; Anil Mishra
Journal:  Clin Immunol       Date:  2015-01-28       Impact factor: 3.969

Review 3.  Role of interleukin-18 in the pathophysiology of allergic diseases.

Authors:  Nathan L Sanders; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2016-07-15       Impact factor: 7.638

4.  AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity.

Authors:  Nicholas W Lukacs; Aaron Berlin; Dominique Schols; Renato T Skerlj; Gary J Bridger
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

5.  Association of interleukin-18 gene polymorphism with asthma in Chinese patients.

Authors:  Cheng-Chun Lee; Wei-Yong Lin; Lei Wan; Yuhsin Tsai; Chang-Hai Tsai; Chung-Ming Huang; Chih-Ping Chen; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

6.  Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model.

Authors:  S Yamagata; K Tomita; R Sato; A Niwa; H Higashino; Y Tohda
Journal:  Clin Exp Immunol       Date:  2008-09-23       Impact factor: 4.330

7.  Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.

Authors:  Asunción Mejías; Susana Chávez-Bueno; Ana María Ríos; Jesús Saavedra-Lozano; Mónica Fonseca Aten; Jeanine Hatfield; Payal Kapur; Ana María Gómez; Hasan S Jafri; Octavio Ramilo
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

8.  Interleukin-18 gene polymorphism, but not interleukin-2 gene polymorphism, is associated with rheumatoid arthritis.

Authors:  Cheng-Chun Lee; Wei-Yong Lin; Lei Wan; Yuhsin Tsai; Ying-Ju Lin; Chang-Hai Tsai; Chung-Ming Huang; Fuu-Jen Tsai
Journal:  Immunogenetics       Date:  2007-03-30       Impact factor: 2.846

9.  Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses.

Authors:  A A Berlin; P Lincoln; A Tomkinson; N W Lukacs
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

10.  Pathway focused protein profiling indicates differential function for IL-1B, -18 and VEGF during initiation and resolution of lung inflammation evoked by carbon nanoparticle exposure in mice.

Authors:  Koustav Ganguly; Swapna Upadhyay; Martin Irmler; Shinji Takenaka; Katrin Pukelsheim; Johannes Beckers; Eckard Hamelmann; Holger Schulz; Tobias Stoeger
Journal:  Part Fibre Toxicol       Date:  2009-12-02       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.